Warfarin Sensitivity
What's New
Last Posted: Oct 22, 2022
- Nine-gene pharmacogenomics profile service: The Mayo Clinic experience.
Matey Eric T et al. The pharmacogenomics journal 2021 10 (1) 69-74 - Differences in predicted warfarin dosing requirements between Hmong and East Asians using genotype-based dosing algorithms.
Sun Boguang et al. Pharmacotherapy 2020 Nov - Influence of SH2B3 , MTHFD1L , GGCX , and ITGB3 Gene Polymorphisms on theVariability on Warfarin Dosage Requirements and Susceptibility to CVD in the Jordanian Population.
Al-Eitan Laith N et al. Journal of personalized medicine 2020 Sep 10(3) - Recommendations for Clinical Warfarin Sensitivity Genotyping Allele Selection: A Report of the Association for Molecular Pathology and College of American Pathologists.
Pratt Victoria M et al. The Journal of molecular diagnostics : JMD 2020 May - Genetic influence on bleeding and over-anticoagulation risk in patients undergoing warfarin treatment after heart valve replacements.
Zhou Ling et al. Expert opinion on drug metabolism & toxicology 2020 Jan 1-9 - Comparison of Two Different Techniques Of Warfarin Dosing Determination - A Chemometrics Study.
Makohusová Miroslava et al. Iranian journal of pharmaceutical research : IJPR 2019 18(2) 1010-1019 - Recommendations for Clinical CYP2C9 Genotyping Allele Selection: A Joint Recommendation of the Association for Molecular Pathology and College of American Pathologists.
Pratt Victoria M et al. The Journal of molecular diagnostics : JMD 2019 May - Impact of CYP2C9 and VKORC1 Polymorphisms on Warfarin Sensitivity and Responsiveness in Jordanian Cardiovascular Patients during the Initiation Therapy.
Al-Eitan Laith N et al. Genes 2018 Nov 9(12) - Universal versus genotype-guided use of direct oral anticoagulants in atrial fibrillation patients: a decision analysis.
You Joyce Hs et al. Pharmacogenomics 2015 Jul 31. 1-12 - Warfarin sensitivity
From NCATS Genetic and Rare Diseases Information Center
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 30, 2024
- Content source: